Mark Laporta, MD
Internal Medicine Physician in Roseland, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Mark Laporta, MD reported a CMS MIPS final score of 83.9/100 - above the 83.5 national average - and filed 929 Medicare Part D claims in 2023.
- 83.9/100
- MIPS score · +0 vs avg
- 929
- Part D claims, 2023
- Likely
- board-certified (heuristic)
- ≥39th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Laporta, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720168826), first enumerated 10/16/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 929 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 83.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Laporta, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720168826 · Internal Medicine Physician
NPI-10 · ENUM-LEGACY · TAX-MEGA · MIPS-INLINE · RX-LIGHT · BOOK-MID · PHOTO-FINISH
- NPI-10 1720168826
- ENUM-LEGACY 2006
- TAX-MEGA 173K Internal Medicine
- MIPS-INLINE 83.9/100
- RX-LIGHT 929
- BOOK-MID 11,125 in Florida
- PHOTO-FINISH Roger Alvarado · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Laporta · this p…
Laporta · this provider
83.9 MIPS pts
- Patricia Burch ·…
Patricia Burch
83.9 MIPS pts
- Roger Alvarado ·…
Roger Alvarado
83.9 MIPS pts
- Jerry Banks · near
Jerry Banks
83.9 MIPS pts
- Joseph Bosarge ·…
Joseph Bosarge
83.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Laporta, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
84 ≥ 39th percentile 39% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Laporta, MD sits
This provider among internal medicine physician peers
Across the 34,612 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Laporta, MD writes more Part D claims than 55% of them and scores higher on MIPS quality than 40% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Mark Laporta, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Mark Laporta, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Laporta, MD?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Florida
How Internal Medicine Physician compares to other specialties among Florida providers
Internal Medicine Physician ranks #9 among Florida's specialties (2.4% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mark Laporta, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 83.9/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Specialty volume Internal Medicine Physician US NPIs
83.9/100 MIPS final score - 0.4 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720168826 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/16/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Laporta, MD's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1720168826 is the unique 10-digit identifier CMS uses to link Laporta across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mark Laporta, MD. To verify Mark Laporta, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,415
- Total Day Supply
- 71,630
- Generic Drug Cost
- $12K
- Antibiotic Claims
- 19
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.67
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 22, 65-74: 104, 75-84: 56, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Laporta, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
76 claims
- Atorvastatin Calcium
Atorvastatin Calcium
66 claims
- Lisinopril
Lisinopril
60 claims
- Losartan Potassium
Losartan Potassium
39 claims
- Metformin Hcl
Metformin Hcl
37 claims
- Hydrochlorothiazide
Hydrochlorothiazide
35 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
35 claims
- Levothyroxine Sodium 26
Levothyroxine Sodium
26 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 76 |
| Atorvastatin Calcium | 66 |
| Lisinopril | 60 |
| Losartan Potassium | 39 |
| Metformin Hcl | 37 |
| Hydrochlorothiazide | 35 |
| Rosuvastatin Calcium | 35 |
| Levothyroxine Sodium | 26 |
| Simvastatin | 23 |
| Metoprolol Succinate | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Mark Laporta, MD fits within the Internal Medicine Physician landscape nationally.
Mark Laporta, MD's 929 claims are below the specialty average of 2,716.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Laporta, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (83.9 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Laporta.
One of 11,125 Internal Medicine Physician providers enrolled in Florida, 5 are shown here.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Laporta, MD's specialty? ▼
How much does Mark Laporta, MD prescribe under Medicare Part D? ▼
What is Mark Laporta, MD's Medicare quality score? ▼
Where is Mark Laporta, MD located? ▼
What is Mark Laporta, MD's NPI number? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Mark Laporta, MD prescribe most often? ▼
Does Mark Laporta, MD accept Medicare? ▼
How can I verify Mark Laporta, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.